News

The S&P 500 is ‘extremely concentrated,’ Apollo economist says, warning the best AI investment may not be in the Magnificent 7
The textbook idea that the S&P 500 gives you a diversified exposure to risk is just simply no longer the case,” Apollo ...
S&P 500’s Humming Profit Engine Can Keep Powering Stocks Rally
A solid earnings season shows Corporate America’s profit engine is humming along, potentially easing worries that the ...
S&P 500 posts fifth straight record close this week, powered by solid earnings: Live updates
Friday marked another winning day for the S&P 500 and Nasdaq, as both indexes posted fresh all-time intraday and closing ...
Myth-Busting The S&P 500 Index In 3 Charts
If the S&P 500 has been such a great investment, surely adding a few smart tweaks should make it even better, right? That’s ...
Is now a good time to invest in the S&P 500? I’m 66, retired and have $200K to invest.
On Friday, the S&P 500 achieved its fifth consecutive record finish, its longest streak of record closing highs since July 10 ...
Is the Vanguard S&P 500 Index Fund ETF a Buy Now?
The S&P 500 is at an all-time high, but that doesn’t necessarily mean it’s a bad time to invest. The S&P 500 is at its ...
S&P 500 Keeps Its Streak of Records Alive
The S&P 500 ended every day this week at a new high. The moves have been modest—on Thursday, the index advanced just ...
S&P 500, Nasdaq end with record highs again. Dow jumps, too.
US stocks end up on earnings, data showing a resilient economy and trade deall optimism. S&P 500 and Nasdaq score records ...
A reminder that S&P 500 returns are highly concentrated on the index's biggest companies
"If you had invested $1 million in the S&P 500 on January 1, 2021, your return today would be $660,000, of which more than ...
S&P 500 Gains and Losses Today: Index Closes Out Q2 With Another All-Time High
The S&P 500 added 0.5% on Monday, June 30, closing the second quarter at record levels amid optimism about trade talks.
2 Healthcare Stocks That Are Losing to the S&P 500 This Year
Novo Nordisk ( NVO 1.34%) and Regeneron Pharmaceuticals ( REGN -0.27%), two leading drugmakers, have underperformed for most ...